"Gout Suppressants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.
| Descriptor ID |
D006074
|
| MeSH Number(s) |
D27.505.954.329.337
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gout Suppressants".
Below are MeSH descriptors whose meaning is more specific than "Gout Suppressants".
This graph shows the total number of publications written about "Gout Suppressants" by people in this website by year, and whether "Gout Suppressants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 6 | 7 | 13 |
| 2018 | 13 | 2 | 15 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Gout Suppressants" by people in Profiles.
-
Meta-analysis of the Effect of Colchicine on Mortality and Mechanical Ventilation in COVID-19. Am J Cardiol. 2021 04 15; 145:170-172.
-
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes. Am J Cardiovasc Drugs. 2021 Sep; 21(5):499-512.
-
Pharmacist-managed titration of urate-lowering therapy to streamline gout management. Rheumatol Int. 2019 Sep; 39(9):1637-1641.
-
Fresh Perspectives on the CARES Trial and the Use of Febuxostat in an Asian Population: Comment on the Article by Choi et al. Arthritis Rheumatol. 2019 03; 71(3):479-481.
-
Uric acid and xantine-oxidase inhibitors in patients with gout: A re-assessment and an update. Cardiol J. 2019; 26(1):99-101.
-
Gout - An update of aetiology, genetics, co-morbidities and management. Maturitas. 2018 Dec; 118:67-73.
-
A first case of human herpesvirus-6B reactivation, confirmed by next-generation sequencing, in allopurinol-induced hypersensitivity syndrome in China. Eur J Dermatol. 2018 Oct 01; 28(5):698-699.
-
Febuxostat for the treatment of hyperuricaemia in gout. Expert Opin Pharmacother. 2018 Aug; 19(11):1289-1299.
-
Allopurinol Dose Escalation and Mortality Among Patients With Gout: A National Propensity-Matched Cohort Study. Arthritis Rheumatol. 2018 08; 70(8):1298-1307.
-
Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Ann Rheum Dis. 2018 08; 77(8):1187-1193.